1.Intravesical Therapy for Superficial Bladder Cancer: Advances and Future.
Korean Journal of Urology 2000;41(4):467-479
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
2.T1 bladder tumor: a heterogeneous and potentially dangerous group.
Journal of the Korean Cancer Association 1991;23(4):843-852
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
3.Expression of p21(waf1/cip1) Protein in Bladder Cancer and its Prognostic Value.
Hwal LEE ; Houng Gyu SOHN ; Dal Bong HA ; Ki Kwon KIM ; Kyung Seop LEE
Korean Journal of Urology 2000;41(7):826-832
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
4.Significance of T1 Substaging on the Recurrence and Progression of Bladder Cancer.
Yong Jae KIM ; Kyung Hyun MOON ; Kyu Rae KIM ; Choung Soo KIM
Korean Journal of Urology 2000;41(11):1323-1328
No abstract available.
Recurrence*
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
5.Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8).
Kwang Joon KIM ; Sun Ok SONG ; Byung Wan LEE
Diabetes & Metabolism Journal 2013;37(1):83-84
No abstract available.
Thiazolidinediones
;
Urinary Bladder
;
Urinary Bladder Neoplasms
7.Prognostic indexes in patients treated with intravesical bacillus calmette-guerin for superficial bladder cancer.
Choal Hee PARK ; Chun Il KIM ; Sung Choon LEE
Journal of the Korean Cancer Association 1991;23(4):835-842
No abstract available.
Bacillus*
;
Humans
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
8.Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8).
Sun Ok SONG ; Kwang Joon KIM ; Byung Wan LEE
Diabetes & Metabolism Journal 2012;36(6):462-463
No abstract available.
Thiazolidinediones
;
Urinary Bladder
;
Urinary Bladder Neoplasms
10.The Direct Anti-Cancer Effect of a Single Instillation of Epirubicin after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer.
Yu Seob SHIN ; Ji Yong KIM ; Oh Seok KO ; A Ram DOO ; Myung Ki KIM ; Young Beom JEONG ; Hyung Jin KIM
Korean Journal of Urology 2012;53(2):78-81
PURPOSE: To evaluate the direct anti-cancer effect of a single instillation of epirubicin (SIE) after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC) by analysis of immediate urine cytology (IUC). MATERIALS AND METHODS: We reviewed the records of 158 patients who had IUC after TURBT for NMIBC. Fifty-six patients were treated with SIE after TURBT and 102 patients were not treated with SIE. The direct anti-cancer effect of SIE was compared in the two groups according to the result of IUC. The relationship between SIE and IUC in NMIBC was analyzed by use of multivariate Cox proportional hazards regression models. RESULTS: The IUC-positive rate was 33.9% in the SIE group and 42.1% in the non-SIE group (p=0.005). The IUC-positive rate was lower in the SIE group than in the non-SIE group for each factor, including tumor stage, tumor grade, tumor size, tumor multiplicity, and preoperative urine cytology. Multivariate Cox proportional hazards regression analysis revealed that SIE was significantly associated with a negative IUC result in patients with NMIBC (HR, 0.163) (p<0.001). CONCLUSIONS: These results indicate the direct anti-cancer effect of SIE in patients who undergo TURBT for NMIBC.
Epirubicin
;
Humans
;
Urinary Bladder
;
Urinary Bladder Neoplasms
Result Analysis
Print
Save
E-mail